NeuroSense Therapeutics Statistics

Total Valuation

NRSN has a market cap or net worth of $36.46 million. The enterprise value is $33.16 million.

Market Cap	36.46M
Enterprise Value	33.16M

Important Dates

The next estimated earnings date is Monday, June 23, 2025, before market open.

Earnings Date	Jun 23, 2025
Ex-Dividend Date	n/a

Share Statistics

NRSN has 23.99 million shares outstanding. The number of shares has increased by 36.38% in one year.

Current Share Class	23.99M
Shares Outstanding	23.99M
Shares Change (YoY)	+36.38%
Shares Change (QoQ)	+12.72%
Owned by Insiders (%)	50.29%
Owned by Institutions (%)	0.97%
Float	11.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.67
P/TBV Ratio	14.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.03.

Current Ratio	2.21
Quick Ratio	1.78
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2,478.16% and return on invested capital (ROIC) is -1,191.29%.

Return on Equity (ROE)	-2,478.16%
Return on Assets (ROA)	-159.50%
Return on Invested Capital (ROIC)	-1,191.29%
Return on Capital Employed (ROCE)	-383.35%
Revenue Per Employee	n/a
Profits Per Employee	-$600,588
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.58% in the last 52 weeks. The beta is 1.34, so NRSN's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+22.58%
50-Day Moving Average	1.09
200-Day Moving Average	1.10
Relative Strength Index (RSI)	69.90
Average Volume (20 Days)	249,972

Short Selling Information

The latest short interest is 163,707, so 0.68% of the outstanding shares have been sold short.

Short Interest	163,707
Short Previous Month	200,177
Short % of Shares Out	0.68%
Short % of Float	1.37%
Short Ratio (days to cover)	1.40

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.90M
Pretax Income	-10.11M
Net Income	-10.21M
EBITDA	-9.88M
EBIT	-9.90M
Earnings Per Share (EPS)	-$0.55

Full Income Statement

Balance Sheet

The company has $3.38 million in cash and $73,000 in debt, giving a net cash position of $3.31 million or $0.14 per share.

Cash & Cash Equivalents	3.38M
Total Debt	73,000
Net Cash	3.31M
Net Cash Per Share	$0.14
Equity (Book Value)	2.58M
Book Value Per Share	0.11
Working Capital	2.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.14 million and capital expenditures -$3,000, giving a free cash flow of -$10.14 million.

Operating Cash Flow	-10.14M
Capital Expenditures	-3,000
Free Cash Flow	-10.14M
FCF Per Share	-$0.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.38%
Shareholder Yield	-36.38%
Earnings Yield	-28.00%
FCF Yield	-27.80%

Analyst Forecast

The average price target for NRSN is $14.00, which is 821.05% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	821.05%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2